Concepedia

Michael D. Altman

MD

47

Publications

3.2K

Citations

27

H-Index

1969

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Massachusetts Institute of Technology

United States Military Academy

University of Massachusetts Chan Medical School

Biotechnology Institute

Michael D. Altman is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, drug discovery, and pharmacology.

Top concepts

MedicinePharmacologyDrug DiscoveryNatural SciencesBiochemistryMedicinal ChemistryMolecular BiologyPharmacotherapyEngineeringChemical Biology

Publications per year

1969–2023

47

Publications

47

An orally available non-nucleotide STING agonist with antitumor activity

Bo‐Sheng Pan, Samanthi A. Perera, Jennifer Piesvaux et al. · Science · 2020 · 609 citations

Antitumor Activity, Immunology, Immunoediting +19

Biological surface engineering: a simple system for cell pattern formation

Shuguang Zhang, Lin Yan, Michael D. Altman et al. · Biomaterials · 1999 · 346 citations

Tissue Engineering, Pattern Formation, Biomimetic System +12

Discovery of a Novel cGAMP Competitive Ligand of the Inactive Form of STING

Tony Siu, Michael D. Altman, Gretchen A. Baltus et al. · ACS Medicinal Chemistry Letters · 2018 · 163 citations · Full text

Peptide self-assembly in functional polymer science and engineering

Shuguang Zhang, Michael D. Altman · Reactive and Functional Polymers · 1999 · 162 citations

Engineering, Peptide Engineering, Molecular Self-assembly +9

Conformational behavior of ionic self‐complementary peptides

Michael D. Altman, Peter Lee, Alexander Rich et al. · Protein Science · 2000 · 148 citations · Full text

Rows per page

1–5 of 47